These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28445899)

  • 1. Evidence-Based Guidelines for the Pharmacologic Management of Methamphetamine Dependence, Relapse Prevention, Chronic Methamphetamine-Related, and Comorbid Psychiatric Disorders in Post-Acute Settings.
    Härtel-Petri R; Krampe-Scheidler A; Braunwarth WD; Havemann-Reinecke U; Jeschke P; Looser W; Mühlig S; Schäfer I; Scherbaum N; Bothe L; Schaefer C; Hamdorf W
    Pharmacopsychiatry; 2017 May; 50(3):96-104. PubMed ID: 28445899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report.
    Tucker MG; Kekulawala S; Kent M; Mostafa S; Harvey R
    J Med Case Rep; 2016 Sep; 10(1):242. PubMed ID: 27599617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatments for methamphetamine abuse: a literature review for the clinician.
    Brackins T; Brahm NC; Kissack JC
    J Pharm Pract; 2011 Dec; 24(6):541-50. PubMed ID: 22095579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis.
    Sulaiman AH; Gill JS; Said MA; Zainal NZ; Hussein HM; Guan NC
    Int J Psychiatry Clin Pract; 2013 Jun; 17(2):131-8. PubMed ID: 22486597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.
    Grelotti DJ; Kanayama G; Pope HG
    Am J Psychiatry; 2010 Jan; 167(1):17-23. PubMed ID: 20068123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine.
    Harro J
    Int Rev Neurobiol; 2015; 120():179-204. PubMed ID: 26070758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine psychosis: epidemiology and management.
    Glasner-Edwards S; Mooney LJ
    CNS Drugs; 2014 Dec; 28(12):1115-26. PubMed ID: 25373627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking, methamphetamine-dependent men who have sex with men.
    Peck JA; Shoptaw S; Rotheram-Fuller E; Reback CJ; Bierman B
    J Addict Dis; 2005; 24(3):115-32. PubMed ID: 16186088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
    Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine-Related Disorders.
    Gouzoulis-Mayfrank E; Härtel-Petri R; Hamdorf W; Havemann-Reinecke U; Mühlig S; Wodarz N
    Dtsch Arztebl Int; 2017 Jun; 114(26):455-461. PubMed ID: 28705298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced psychosis associated with crystalline methamphetamine.
    Dore G; Sweeting M
    Australas Psychiatry; 2006 Mar; 14(1):86-9. PubMed ID: 16630206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.
    Sulaiman AH; Said MA; Habil MH; Rashid R; Siddiq A; Guan NC; Midin M; Nik Jaafar NR; Sidi H; Das S
    Compr Psychiatry; 2014 Jan; 55 Suppl 1():S89-94. PubMed ID: 23433219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis.
    Ujike H; Sato M
    Ann N Y Acad Sci; 2004 Oct; 1025():279-87. PubMed ID: 15542728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment for dual diagnosis: a literature update and a proposal of intervention.
    Vitali M; Mistretta M; Alessandrini G; Coriale G; Romeo M; Attilia F; Rotondo C; Sorbo F; Pisciotta F; Attilia ML; Ceccanti M;
    Riv Psichiatr; 2018; 53(3):160-169. PubMed ID: 29912219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of methamphetamine use disorder treated with the antibiotic drug minocycline.
    Tanibuchi Y; Shimagami M; Fukami G; Sekine Y; Iyo M; Hashimoto K
    Gen Hosp Psychiatry; 2010; 32(5):559.e1-3. PubMed ID: 20851278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users.
    McKetin R; Gardner J; Baker AL; Dawe S; Ali R; Voce A; Leach LS; Lubman DI
    Psychiatry Res; 2016 Apr; 238():166-171. PubMed ID: 27086229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report.
    Ricci V; Di Salvo G; Maina G
    J Addict Dis; 2022; 40(1):145-148. PubMed ID: 34180372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors.
    Akindipe T; Wilson D; Stein DJ
    Metab Brain Dis; 2014 Jun; 29(2):351-7. PubMed ID: 24532047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.